Wednesday 03 July 2024
Internal Reference Number: FOI_6905
Date Request Received: 08/12/2022 00:00:00
Date Request Replied To: 19/01/2023 00:00:00
This response was sent via: By Email
Request Summary: Dermatological conditions
Request Category: Companies
| Question Number 1: How many patients were treated in last 4 months by the Dermatology department with each of the following: • Abrocitinib • Acitretin • Alitretinoin • Azathioprine • Baricitinib • Ciclosporin • Dupilumab • Methotrexate • Mycophenolate mofetil • Pimecrolimus • Tacrolimus ointment • Tralokinumab • Upadacitinib • Phototherapy (UVB or PUVA) | |
| Answer To Question 1: • Abrocitinib - 0 • Acitretin - 36 • Alitretinoin - 6 • Azathioprine - 5 • Baricitinib - 0 • Ciclosporin - 6 • Dupilumab - 18 • Methotrexate - 24 • Mycophenolate mofetil - 2 • Pimecrolimus - 5 • Tacrolimus ointment - 32 • Tralokinumab - 1 • Upadacitinib - 0 • Phototherapy (UVB or PUVA) - 0 | |
| Question Number 2: Of the patients treated in the last 4 months with any of the products listed in Q1, please provide the number of patients by the following age-groups: • Age 6-11 • Age 12-17 • Age 18 and above | |
| Answer To Question 2: This information is not reported by the Pharmacy system. | |
| Question Number 3: If possible, could you please provide the number of patients treated in the last 4 months for atopic dermatitis ONLY with: • Azathioprine • Ciclosporin • Methotrexate • Mycophenolate mofetil • Phototherapy (UVB or PUVA) | |
| Answer To Question 3: • Azathioprine - This information is not recorded in a format that is easily accessible and would take over the allocated timeframe to answer. • Ciclosporin - This information is not recorded in a format that is easily accessible and would take over the allocated timeframe to answer. • Methotrexate - This information is not recorded in a format that is easily accessible and would take over the allocated timeframe to answer. • Mycophenolate mofetil - This information is not recorded in a format that is easily accessible and would take over the allocated timeframe to answer. • Phototherapy (UVB or PUVA) - 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
